Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Angelillo-Scherrer

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Swiss Medical Weekly|March 15, 2018
How I manage patients with anticoagulation-associated bleeding or urgent surgeryThomas C Sauter, Balthasar Eberle, Walter A Wuillemin, et al.
Bioanalysis|October 22, 2013
Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoformBertrand Rochat, Davide Peduzzi, Justin McMullen, et al.
The American Journal of Medicine|June 14, 2017
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?Marie Méan, Andreas Limacher, Odile Stalder, et al.
European Journal of Gastroenterology & Hepatology|August 17, 2018
Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseasesNathalie I Caversaccio, Maria D Reina Caro, Raja Prince, et al.
Leukemia & Lymphoma|January 4, 2018
Coincidence of 5q deletion and the JAK2V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literatureSusanne Bürki, Evgenii Shumilov, Nicolas Bonadies, et al.
Journal of Innate Immunity|November 8, 2023
Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19Tiphaine Ruggeri, Yasmin De Wit, Noëlia Schärz, et al.
Hematological Oncology|March 8, 2019
Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutationsEvgenii Shumilov, Johanna Flach, Raphael Joncourt, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variabilitySara Calzavarini, Justine Brodard, Claudia Quarroz, et al.
Blood Advances|September 12, 2019
Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndromeAnne Angelillo-Scherrer, Behrouz Mansouri Taleghani, Frauke Förger, et al.
Annals of Hematology|February 9, 2026
Long-term real-world thrombotic and clinical outcomes in polycythemia vera - a hospital-based i2b2 cohort studyNatalie Neumark, Katarzyna Aleksandra Jalowiec, Andre Tichelli, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Swiss Medical Weekly|March 15, 2018
How I manage patients with anticoagulation-associated bleeding or urgent surgeryThomas C Sauter, Balthasar Eberle, Walter A Wuillemin, et al.
Bioanalysis|October 22, 2013
Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoformBertrand Rochat, Davide Peduzzi, Justin McMullen, et al.
The American Journal of Medicine|June 14, 2017
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?Marie Méan, Andreas Limacher, Odile Stalder, et al.
European Journal of Gastroenterology & Hepatology|August 17, 2018
Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseasesNathalie I Caversaccio, Maria D Reina Caro, Raja Prince, et al.
Leukemia & Lymphoma|January 4, 2018
Coincidence of 5q deletion and the JAK2V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literatureSusanne Bürki, Evgenii Shumilov, Nicolas Bonadies, et al.
Journal of Innate Immunity|November 8, 2023
Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19Tiphaine Ruggeri, Yasmin De Wit, Noëlia Schärz, et al.
Hematological Oncology|March 8, 2019
Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutationsEvgenii Shumilov, Johanna Flach, Raphael Joncourt, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variabilitySara Calzavarini, Justine Brodard, Claudia Quarroz, et al.
Blood Advances|September 12, 2019
Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndromeAnne Angelillo-Scherrer, Behrouz Mansouri Taleghani, Frauke Förger, et al.
Annals of Hematology|February 9, 2026
Long-term real-world thrombotic and clinical outcomes in polycythemia vera - a hospital-based i2b2 cohort studyNatalie Neumark, Katarzyna Aleksandra Jalowiec, Andre Tichelli, et al.
Pageof 11